chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood pressure spike to 190/110, Temperature increase to 100 degrees F, Heart rate accelerated to 120 bpm, body shakes, tingling sensation all the way down to finger tips, within 20 minutes of vaccine administration. Sent the emergency room and monitored for 4 hours until vital returned to normal.
Initial unsolicited report received from a health care professional on 11-Jan-2018. This case involves a 55-year-old male patient who was vaccinated with 0.5 ml dose of ADACEL (Batch number: C5220AA, expiry date and dose in series were not reported) via intramuscular route at right arm on 10-Nov-2017. Patient's medical history and concomitant medications were not reported. On an unknown day following the vaccination, the patient had right arm weakness and could not lift his right arm over his shoulder and was seen by doctor today. Laboratory investigations and corrective treatment were not reported. Outcome of both the events were not recovered at time of reporting. Documents held by sender: none.
Child had swelling, redness, warmth and itching to left arm at sites where DTaP and varicella were administered.
It was reported that 4 children who rec'd a dose of Tripedia vaccine (lot U0583AA) All 4 pt's experienced local reactions of redness and swelling. No additional information was provided. see cases U2002-00803 to U202-00805, same reporter.
They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Vials were moved to fridge on 06-Oct-2021.  Treatment details was not reported by the reporter.
Sores on scalp from 1 month after shot until two months after diagnosis of Type 1 Diabietes. Complaints started in February - fatigue, muscle aches, stomach aches, eye strain, hunger an then extreme thirst. Loss of weight caused us to have her treated for Diabetes. Follow up on 01/03/2003: "Lot # for Hep A was not recorded." Per follow up: pt has recovered from head sores after 11 months. No she has not recovered from Type I diabetes. Pt is presently undergoing intensive nutritional therapy in addition to the expense of her diabetes care. Annual follow up on 02/17/04: "Pt has not recovered from adverse events.  The sores on her head went away after 11 months. She still has Type I Juvenile Diabetes. Does anyone recover from Type I Diabetes?
Severe muscle pain and weakness, could hardly walk; severe chills; fever; tiredness; swelling and pain at injection site; stomach pain & nausea; headache; rash at injection site.
pt recvd vax & exp swelling, discomfort, & fasciculation at inject site; pt taken to ER for tx & recvd a muscle relaxant;
Urticarial rash started the evening of 11/13 and then spread to patient's trunk, groin, arms, legs, and face. Mom has been treating child with oral Benadryl which makes itching a little better but produces no change in the rash itself.
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored GARDASIL 9 (dose, route of administration, lot# and expiration date were not provided). No adverse effects were reported. Temperature and time frame: 32 degrees Fahrenheit to 35 degrees Fahrenheit for 67 minutes and 47 degrees Fahrenheit to 77 degrees Fahrenheit for 139 minutes. Previous temperature excursion?: No. Was call because of a "data logger"?: Yes. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1708USA013411:
After each dose, new neurological symptoms manifested; I felt like I was sedated; My whole body was shutting down; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP), Program ID. A female patient in her 60's received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Vivaxim, administration date: 2008, for Immunization, reaction(s): "Guillain-Barre syndrome"; Dukoral, administration date: 2008, for Immunization, reaction(s): "Guillain-Barre syndrome". The following information was reported: NERVOUS SYSTEM DISORDER (non-serious), outcome "unknown", described as "After each dose, new neurological symptoms manifested"; SEDATION (non-serious), outcome "unknown", described as "I felt like I was sedated"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "My whole body was shutting down".  Additional information: She was no stranger to neurological vaccine side effects. In 2008, she developed Guillain-Barre syndrome due to taking Vivaxim and Dukoral for travel. Her legs gave out, and she was bedridden, although her symptoms disappeared after she went on supplement protocols. In 2021, COVID-19 vaccinations were mandated in her workplace, so she got the COVID-19 vaccine to keep her job. After each dose, new neurological symptoms manifested. Before 2021, she ran more than three miles daily and could cycle up to 46 miles on her bike despite being in her 60s. But her life changed 15 minutes after she got her first of two COVID-19 vaccine doses. "I felt like I was sedated," she told about her experience after the first dose. "My whole body was shutting down."   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
within (1) day I developed a chronic colitis, bloating, severe abdominal pain, nausea, unable to tolerate foods, developed gluten intolerance ie. Celiac and developed lactose intolerance after having eaten these foods my whole life
Pt described severe rash on both lower legs and severe neuropathy lasting for days. Note that this was 5 year ago and given elsewhere.
The next day after the vaccine I experienced joint pain and fever of 101. The joint pain lasted 2-3 days. Since then at intermittent times, the inside of both ankles has a scarlet rash, then joint pain and swelling at the rash that goes into my foot. This last from 3-5 days. I apply a cream to reduce inflammation and if it does not go away, I will take a Zyrtec. It will go away then will flare up again. The last event happen 4/13/2022 which lasted 4 days. I had a total of at least 3-4 episodes of this since my 3rd dose. I went to a dermatologist and discussed this issue with no recommendation but did get a prescription of a topical lotion which did not work as well. I do have a future appointment with my PCP to get testing. I never had joint pain before this except for a past injury.
Dose given was for age 5 - 11 y/o, patient is 20 y/o.  No adverse event, only incorrect dose given.
0810 hrs on 17 Aug 2006 Approximately 25 minutes after JEV and IPV Vaccination the patient stated she felt right side throat tightness.  0812 hrs Patient was given Epi-pen auto injector, vitals monitored 0817 hrs Benadryl IM, 0900hrs oral prednizone, 1000hrs epi-pen auto injector because patient stated she still had very slight right side throat tighntess. She was released with a full recovery at 1110hrs. Her significant other drove her away from the facility.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced mild chickenpox with less than 50 faint red papules on the trunk.
Treatment of COVID-19; Treatment of COVID-19; Covid symptoms were in my chest; exhaustion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Mar2021 at 15:45 as dose 1, single (Lot number: EP7533), in right arm, on 15Apr2021 as dose 2, single (Lot number: EW0169), in right arm, on 22Oct2021 at 14:00 as dose 3 (booster), single (Lot number: FH8020), in right arm and on 15Jun2022 at 13:00 as dose 4 (booster), single (Lot number: FM7553) at the age of 65 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "back fusion" (unspecified if ongoing); "Known allergies: sulfa" (unspecified if ongoing); "Known allergies: lactose intolerant" (unspecified if ongoing). Concomitant medication(s) included: ALENDRONATE SODIUM, start date: 19Jul2021 (ongoing). The following information was reported: CHEST DISCOMFORT (non-serious) with onset 2022, outcome "unknown", described as "Covid symptoms were in my chest"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19"; FATIGUE (non-serious) with onset 2022, outcome "unknown", described as "exhaustion". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Indication=Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient received other medications in two weeks. Patient received Covid-19 treatment with Paxlovid from 13Oct2022 to 18Oct2022. Six days after completing patient final dose of Paxlovid, She had a "rebound". Patient original Covid symptoms were in her chest, exhaustion. Patient rebound was an intense head cold, exhaustion, dizziness. She felt worse during the rebound and it took over 10 days to recover - 10 days in addition to the 10 days of original Covid. Infrequently, Patient still become light headed.
She got a fever of 103.0 day 2 8/21/10 in the evening. Had a headache & c/o trouble breathing. Day 3 c/o trouble breathing but seemed okay when checked by mom.
Became ill:  weakness, uncontrollable shakes, fever 100.9, very cold/chilled, thirst, body aches, injection sight ache.   The discomfort in arm is slowly getting better....but it's 2.5 days later and not gone.  Furthermore, my arm injection sight is red and warm to the touch.
Patient felt throat closing, she had a very hard time breathing. She was dizzy, almost couldn't stand, she was coughing non stop (barking cough).
Also had flu vaccine same time, but unsure of specifics of that shot. Around 24 hours after vaccinations, began to feel lethargic and diarrhea (every hour or so) began. At 36 hours, fever rose to 103. Dizziness caused an overnight fall. Fever (mostly 100-101), weakness, chills,  dehydration (received two liters of IV fluids on day 3) and chronic diarrhea continued next six days. On day 7, symptoms (all but occasional diarrhea) subsided.
Initial report received from a healthcare professional on 15 JULY 2013. A 77-year-old female patient, with allergy to PCN (Penicillin) , no illness at the time vaccination and whose concomitant medications were not reported, had received an intramuscular dose of ADACEL (batch number and anatomical site of administration were not reported) on 10 JULY 2013. On 12 JULY 2013, the patient presented with injection site reaction which was red, itchy, tender to touch and swollen measuring 7 inches from side to side, 3 inches from top to bottom. No laboratory tests were done. The corrective treatment was not reported. At the time of this report, the patient had not recovered from the events. Documents held by sender: none
She ran a low grade fever after the shot and into the evening. That afternoon and evening she was fussy and wouldn't nap. When she woke up the next morning she was extremely fussy and cried all day non stop. She wouldn't nap still. When we went to give her a bath at 7:30 we noticed a spotty red rash with tiny bumps covering her body. The rash is different than her eczema. I will call the doctor in the morning.
discovered a sore early the next morning that appeared to be the type from a blister where the blister skin had been pulled off.  This sore was 1inch by 1inch approximately on my right buttocks near the base of my spine.
Pain, warmth and swelling of arm at site of vaccine administration.  Fever of 102.  Patient reported achiness and weakness.  Diagnosis of cellulitis made per MD.  Patient took Augmentin and Medrol dose pack x 2 days without relief.  Patient then received Rocephin IM x 2 days with full resolution in 72 hours.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pharmacist call because they gave a expired vaccine) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2022 at 11:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pharmacist call because they gave a expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pharmacist call because they gave a expired vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient height was reported as 5 feet 9 inches. Patient had no allergies related to medications, food and other products. There was no concomitant list provided by the reporter. Patient did not received other vaccines within 1 month prior to Moderna COVID-19 vaccine. It was unknown whether AE cause patient to seek medical care. It was unknown whether patient experienced a similar event in the past and the symptoms were improved or worsened. It was unknown whether patient ever had COVID positive test or diagnosis. No treatment information was provided. It was reported that vials were never stored in the refrigerator and were kept at -12 degree Fahrenheit. When vial was took out of the freezer was left for 2 hours at room temperature. This case was linked to MOD-2022-482624 (Patient Link).
left arm shaking; sweating; every bone in the body aches; really bad headaches; left arm hurts/pain in both arms; right shoulder hurts; pain in front of the chest to the back side on the right side; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (left arm shaking), HYPERHIDROSIS (sweating), CHEST PAIN (pain in front of the chest to the back side on the right side), BONE PAIN (every bone in the body aches) and PAIN IN EXTREMITY (left arm hurts/pain in both arms) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN (ADVIL 12 HOUR), INSULIN, FUROSEMIDE, ATORVASTATIN, SALBUTAMOL (ALBUTEROL HFA), METFORMIN, GABAPENTIN, LANSOPRAZOLE, TOPIRAMATE, GLIPIZIDE and MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE] for an unknown indication.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced CHEST PAIN (pain in front of the chest to the back side on the right side), PAIN IN EXTREMITY (left arm hurts/pain in both arms) and ARTHRALGIA (right shoulder hurts). On 02-May-2021, the patient experienced TREMOR (left arm shaking), HYPERHIDROSIS (sweating), BONE PAIN (every bone in the body aches) and HEADACHE (really bad headaches). At the time of the report, TREMOR (left arm shaking), HYPERHIDROSIS (sweating), CHEST PAIN (pain in front of the chest to the back side on the right side), BONE PAIN (every bone in the body aches), PAIN IN EXTREMITY (left arm hurts/pain in both arms), ARTHRALGIA (right shoulder hurts) and HEADACHE (really bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment info provided.
severe damage to his heart; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (RA). The reporter is the parent.  A 20-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown Manufacturer), for Covid-19 Immunization. The following information was reported: MYOCARDIAL INJURY (death) with onset 17Feb2022, outcome "fatal", described as "severe damage to his heart". On 17Feb2022, reporter's son passed away in his sleep after receiving the 2nd dose of Covid vaccine, the vaccine did severe damage to his heart, he was forced to take the vaccine to keep his job. The patient date of death was 17Feb2022. Reported cause of death: "severe damage to his heart". It was not reported if an autopsy was performed.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: severe damage to his heart
Rash-hives after vaccines give 11:20 AM.  09/08/2003: when awoke from his nap that afternoon, seen by physician 09/09/2002 at 15:00 with continued urticaria.
Infant was crying after receiving Pediarix vaccine, Then suddenly became unresponsive during injection. Per MA administering, appeared to stop breathing for a second and was rigid. Resolved without intervention within seconds (less than 5 seconds).  Infant was normal after this, observed in the office for 30 minutes. Vitals were normal.
I noticed when I was at the gym working out that I was having extreme muscle soreness. I had major weakness and fatigue when getting out of chairs. I am out of breath more than often. I haven't contracted COVID-19 or even a Cold.  12/2021 I saw a doctor for the issues and my muscle and liver enzymes were elevated. I also got a muscles biopsy to further confirm issues with my health. I'm getting infusions and immune therapy. I really think its too soon to tell but I have been able to sleep at night.
Erythema and increase warmth, at upper arm extending 6.5cm past the elbow.
Feeling of vertigo when standing up/sitting down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Oct2021 11:30 (Lot number: 30145BA) at the age of 41 years as dose 1, single and administered in arm left, administration date 13Nov2021 13:00 (Lot number: 3013058A) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VERTIGO (non-serious) with onset 08Oct2021 12:00, outcome "not recovered", described as "Feeling of vertigo when standing up/sitting down". Therapeutic measures were not taken as a result of vertigo.  Additional information: It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications the patient received within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19 and Since the vaccination has not been tested for COVID-19. No known allergies. Serious: No.   Follow-up attempts are completed. No further information is expected.
NEAR SYNCOPE. PT BECAME PALE AND STATED HE FELT LIGHTHEADED BUT DID NOT ACTUALLY PASS OUT. WE HAD PATIENT LIE DOWN WITH HIS FEET ELEVATED FOR A BRIEF TIME. AFTER A FEW MINUTES HE SAT BACK UP AND FELT NORMAL AGAIN.
VERTIGO; INABILITY TO CONCENTRATE; DIZZINESS; COULDN'T DRIVE FOR 2 HOURS; NUMBNESS LEFT ARM; PAIN UP AND DOWN LEFT SIDE OF THE BODY; ANXIETY; SWELLING LEFT ARM; NAUSEA; PAIN AT INJECTION SITE; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced vertigo. On 10-MAR-2021, the subject experienced inability to concentrate. On 10-MAR-2021, the subject experienced dizziness. On 10-MAR-2021, the subject experienced couldn't drive for 2 hours. On 10-MAR-2021, the subject experienced numbness left arm. On 10-MAR-2021, the subject experienced pain up and down left side of the body. On 10-MAR-2021, the subject experienced anxiety. On 10-MAR-2021, the subject experienced swelling left arm. On 10-MAR-2021, the subject experienced nausea. On 10-MAR-2021, the subject experienced pain at injection site. On 10-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vertigo on 12-MAR-2021, and inability to concentrate, dizziness, couldn't drive for 2 hours, numbness left arm, pain up and down left side of the body, swelling left arm, nausea, and fatigue on 10-MAR-2021, was recovering from pain at injection site, and had not recovered from anxiety. This report was non-serious.
Injection site pain, swollen lymph nodes under the left armpit,  fainting,  panic attack and anxiety, menstrual changes, acid reflux, vertigo
Pain at site following administration. Noted increased pain and swelling 36 hours later, swelling in arm and on hand, hand feels numb but exam for sharp/dull was normal.